Hematologist
CION Cancer Clinics
Bulky disease in DLBCL and when radiotherapy is added | CION Cancer Clinics
Bulky disease means one mass of lymphoma was large on your first scan. Chemotherapy with rituximab is still the main treatment. Radiotherapy to that one area may be added afterwards, most often when the end-of-treatment PET scan still shows activity there. When the scan is fully clear, many teams now watch instead. This page explains how that choice is made and what it involves. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What does "bulky disease" mean, and why does it bring up radiotherapy?
- When is radiotherapy most likely to be suggested?
- How do chemotherapy alone and chemotherapy plus radiotherapy compare?
- If radiotherapy is planned, what happens next?
- What do the words on the plan mean?
- What do families often get wrong about radiotherapy here?
- Who may not need it, and what can this page not tell you?
- Common questions about bulky DLBCL and radiotherapy
The short answer
What does "bulky disease" mean, and why does it bring up radiotherapy?
Bulky disease means one mass of lymphoma was large when it was first measured on your scan. Because a large mass is more likely to leave a small patch of lymphoma behind after chemotherapy, your team may suggest a short course of radiotherapy to that one area once the chemotherapy is finished.
How big counts as bulky?
There is no single agreed size. Different guidelines and studies have used different cut-offs, often somewhere between 7.5 cm and 10 cm across. A chest mass may also be called bulky if it is wide compared with the chest itself. Your report may simply say "bulky" or give the size, so ask which definition your team is using.
What is DLBCL, in one line?
Diffuse large B-cell lymphoma is a fast-growing cancer of B cells, a kind of white blood cell that lives in the lymph nodes. It is the most common aggressive lymphoma, and chemotherapy with rituximab is the main treatment for almost everyone who has it.
Radiotherapy is an add-on, not the main treatment
For most people with bulky DLBCL, chemotherapy does the heavy work. Radiotherapy, if it is used at all, is a local top-up aimed at the place where the big mass was. The decision is usually made after the scan at the end of chemotherapy, not at the start.
Bring the size and site of the mass from your first scan report to every appointment. The whole discussion turns on it.Weighing it up
When is radiotherapy most likely to be suggested?
No one factor decides it. The team puts these together and discusses them with you.
Something still shows on the end-of-treatment PET
If a part of the old mass is still active on the PET-CT scan after chemotherapy, radiotherapy to that area is one of the options. The team may first want a biopsy to be sure it is lymphoma and not scarring or inflammation.
The mass was very large at the start
The bigger the mass, the more some teams lean towards treating it with radiotherapy, even when the scan looks clear. Other teams now watch and wait instead. Both approaches are used.
Chemotherapy had to be cut short
If side effects or other illnesses meant you could not finish the planned chemotherapy, radiotherapy can help treat the main area of disease more completely.
Where the mass sits
The site changes the balance of benefit and harm.
The team thinks harder about
- The chest, close to the heart and lungs
- The breast area in younger women
- The neck, near the salivary glands and thyroid
Not sure whether this applies to you?
Ask an oncologistSide by side
How do chemotherapy alone and chemotherapy plus radiotherapy compare?
Chemotherapy alone
Chemotherapy, then radiotherapy
Treatment finishes with the last cycle
A few more weeks of short weekday visits
No radiation to healthy tissue near the mass
Some healthy tissue near the mass receives radiation
Relies on the end-of-treatment scan being clear
Adds local treatment where lymphoma is most likely to remain
Often chosen when the PET scan is fully clear
Often chosen when some activity remains
The pathway
If radiotherapy is planned, what happens next?
-
The end-of-treatment scan
A PET-CT is done a few weeks after the last chemotherapy. It shows whether any part of the mass is still active.
-
Tumour board discussion
Your haematologist, a radiation oncologist and a radiologist look at the first scan and the latest one together before a plan is agreed.
-
The planning scan
You lie in the treatment position while a CT scan is taken. Small skin marks or a mask for the neck help put you in the same position each day.
-
The treatment sessions
Sessions are short and usually on weekdays over a few weeks. You lie still, the machine moves around you, and you go home the same day.
-
Follow-up
Side effects tend to peak near the end of the course and settle over the following weeks. Your team decides if and when another scan is needed.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the words on the plan mean?
- Bulky
- A single mass that was large at diagnosis. The exact size cut-off varies between guidelines.
- Consolidation radiotherapy
- Radiotherapy given after chemotherapy has already shrunk the lymphoma, to treat any cells left in that area.
- Involved-site radiotherapy (ISRT)
- Radiation aimed only at the area where the lymphoma was, plus a small safety rim, rather than a wide area of the body.
- Residual mass
- What is still visible on a scan after treatment. It may be scar tissue with no lymphoma in it at all.
- Deauville score
- A five-point scale the PET report uses to describe how active an area still is compared with normal organs.
Commonly believed
What do families often get wrong about radiotherapy here?
"Being offered radiotherapy means the chemotherapy failed."
Not usually. For bulky disease it is often planned from the start as a second step, or offered because a small area is still uncertain. It is a way of finishing the job in one place, not a sign that treatment has gone wrong.
"A lump still showing on the scan must be lymphoma."
A large mass often leaves scar tissue behind. The PET part of the scan shows whether that tissue is still active. A lump that is visible but not active is common and may need no further treatment.
"Radiation will make him radioactive at home."
External radiotherapy does not leave radiation in the body. The machine switches off and nothing stays behind. It is safe to be close to children, older relatives and pregnant family members the same evening.
"More treatment is always the safer choice."
Radiotherapy has its own later effects, especially in the chest. If the scan is clear, some teams judge the extra treatment is not worth it. The right answer depends on your scan, your age and where the mass was.
Being straight with you
Who may not need it, and what can this page not tell you?
Radiotherapy is not right for everyone with bulky DLBCL. People whose end-of-treatment PET scan is fully clear may be offered close watching instead. Studies comparing the two approaches do not all agree, so practice differs between centres, and a different view from another team is not necessarily a mistake.
When the balance tips against it
The team may advise against radiotherapy if the area includes a lot of heart or lung, if you had radiotherapy to the same place before, or if the lymphoma was spread across many sites, so that one field would not cover it. Some lung conditions and some autoimmune illnesses also make radiation harder to give safely.
What this page cannot tell you
It cannot tell you whether your own mass needs radiotherapy, or what your outlook is. Those answers come from your scans, your pathology report and how you responded to chemotherapy. CION's haematology team reviews these at a tumour board and helps you reach a centre that delivers the radiotherapy if it is recommended.
Questions we are asked
Common questions about bulky DLBCL and radiotherapy
Does bulky disease mean the lymphoma is more advanced?
Not by itself. Stage describes how many areas of the body are involved. Bulk describes the size of one mass. You can have an early-stage lymphoma that is bulky, or an advanced one that is not. Both details go into the plan, and your haematologist will explain how they fit together for you.
Is radiotherapy given before or after chemotherapy?
In DLBCL it is almost always given after chemotherapy has finished. Chemotherapy treats the whole body first and shrinks the mass. The end-of-treatment scan then shows whether a local top-up to that area is worth it. Radiotherapy first is rare, and is usually kept for urgent problems such as a mass pressing on a vital structure.
What side effects should we expect?
They depend on where the beam is aimed. The chest can bring a sore throat, trouble swallowing or a cough. The neck can cause a dry mouth. The abdomen can cause feeling sick or loose motions. Tiredness is common everywhere. Most short-term effects settle in the weeks after treatment ends.
Are there long-term effects we should know about?
Some effects can appear years later, which is why modern planning keeps the field small. Chest radiotherapy can affect the heart, lungs or thyroid over time, and in younger women can raise the chance of breast cancer later. Ask your team which later effects apply to your field and what check-ups you will need.
My father's scan still shows a lump. Does he need radiotherapy?
Not automatically. A lump that is visible but not active on PET is often just scar tissue. If part of it is still active, the team will weigh radiotherapy, a biopsy or a repeat scan. Take both the first and the latest scan reports to the appointment so they can be compared side by side.
Can he keep working during radiotherapy?
Many people do, because each session is short and there is no stay in hospital. Tiredness tends to build towards the end of the course. If his job is physically heavy or needs long travel, ask the team early about session times so the daily visits fit around his work.
Is radiotherapy covered by Aarogyasri or insurance?
Radiotherapy that is part of an approved cancer treatment plan is often covered under Aarogyasri, CGHS, ECHS, EHS, PM-JAY and many cashless insurance policies. Scheme rules and package limits change, so check the current terms with the scheme or insurer before treatment starts.
Can we get a second opinion on whether it is needed?
Yes, and because practice differs between centres it is a reasonable thing to ask for. Bring the first scan, the end-of-treatment scan, the biopsy report and a summary of your chemotherapy. CION's haematology team can review these and discuss the options with you before radiotherapy begins.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Adult Non-Hodgkin Lymphoma Treatment (PDQ) - Health Professional Version
- Cancer Research UK — Non-Hodgkin lymphoma
- American Cancer Society — Non-Hodgkin Lymphoma
- NHS — Non-Hodgkin lymphoma: treatment
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
End-of-Treatment PET in DLBCLThe scan that usually decides whether radiotherapy is addedR-CHOP: The Standard Regimen ExplainedThe chemotherapy that comes before any radiotherapyRadiation therapy guideHow radiotherapy sessions work in generalAggressive B-Cell LymphomaThe overview of this lymphoma group
Talk to us
Unsure whether radiotherapy is needed?
Share the first and latest scan reports. CION's haematology team will review them and explain the options. One helpline serves every CION centre.